chrisvoncsefalvay/vaers-outcomes huggingface dataset:
15 persons received Pfizer vaccine from vials that has been reconstituted with 1.3 mL instead of 1.8 mL; 15 persons received Pfizer vaccine from vials that has been reconstituted with 1.3 mL instead of 1.8 mL; Significant body aches; This is a spontaneous report from a contactable physician. This physician reported similar events for 15 patients. This is 3rd of 15 reports. A patient of unspecified age and gender received BNT162B2 (COMIRNATY, Solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration and date (dose number unknown) as single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received pfizer vaccine from vials that has been reconstituted with 1.3 ml instead of 1.8 and they reported significant body aches on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021188834 Same reporter/drug/event, different patient.
This spontaneous report as received from a physician refers to a 5 year old male patient. In July 2016, the RECOMBIVAX HB (lot # M04031 exp: February 2019) series started. On 02-NOV-2016 the patient was vaccinated with a dose of RECOMBIVAX HB for prophylaxis. On 02-MAY-2017 the patient experienced pyrexia, vomiting and nausea. On approximately 04-MAY-2017 the patient experienced dyspnoea and cough. On approximately 11-MAY-2017 the patient experienced hypersensitivity. On approximately 22-MAY-2017 the patient experienced ear pain and wheezing. The outcome of pyrexia, hypersensitivity, wheezing, ear pain, cough, dyspnoea, vomiting and nausea is unknown.
A-FIB; This spontaneous report received from a patient via a company representative through media concerned a patient of unspecified age, sex, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously treated with covid-19 vaccine ad26. cov2. s (unspecified manufacturer) (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (Dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient was having A-Fib (Atrial fibrillation) since the second shot (dose number in series 2). Patient posted that "I have been having A-Fib since the second shot." The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from a-fib. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220237598-COVID-19 VACCINE AD26.COV2.S-a-fib. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
I received it at 10am and around 2am that night I started to have a bad headache and body aches. I would fall asleep for a bit but then at 4am I woke up with the worst headache of my life. It was so unbearable that I would clinch my eyes shut. Bones and muscle pains all over. Violent hot/cold flashes. I would feel hot all over and after a minute or so of placing a cold pack on my head I began to shiver despite sweating. Around 5am I was looking at my phone wondering if I should go to the ER because I legitimately felt like I was in danger.  The unbearable headache lasted a total of 14 hours from its onset. No OTC medications were taken.  Around 6pm on day 2 from the dose the intensity of the headache began to subside VERY slowly.  I woke up on day 3 completely fine as if nothing happened.
experienced Flu; Joint Paint; Fever; Muscle Pain; Headache; Tiredness; Nausea; Arm Pain; Injection Site Pain; He is feeling sick after second dose; This is a spontaneous report from a contactable consumer (patient) from a Pfizer sponsored program . A 26-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm on 20May2021 (at the age of 26-years-old) (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) on an unspecified date (at the age of 26-years-old) for COVID-19 immunisation. The patient reported that he experienced Flu, Joint Paint, Fever, Muscle Pain, Headache, Tiredness, Nausea, Arm Pain and Injection Site Pain. He had his first shot of the Pfizer BioNTech Covid-19 Vaccine last day 20May2021 (as reported). Caller wanted to know if he would be allowed to take Dayquil to relieve the current side effects he was experiencing. The patient received his second dose last day (20May2021) but cannot recall exact date of 1st. He was feeling sick after second dose. His symptoms were not much different than what was on the fact sheet. He did not wish to report them at all. He just had a question. His symptoms were very typical of the flu with the usual joint pain, fever, muscle pain, headache and tiredness. He took the day off of work. He just wanted to know if he should take Dayquil tomorrow so he could function and go to work. The patient was referred to HCP. Outcome of the events was unknown.  Follow-up needed. Information about batch/lot number has been requested.
This spontaneous report was received from a medical assistant via a company representative and refers to a female patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient was vaccinated with the second dose of GARDASIL 9 (dose, route of administration, lot # and expiration date were not provided) as prevention of Human Papilloma Virus (HPV). On an unknown date, after receiving GARDASIL 9, the patient experienced sore throat and nausea. The patient sought medical attention via calling physician. The outcome of sore throat and nausea was unknown. The relatedness between the events and GARDASIL 9 was not reported.
I got Moderna as my 1st dose and Pfizer as my 2nd dose; having headaches on and off still; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (I got Moderna as my 1st dose and Pfizer as my 2nd dose) and HEADACHE (having headaches on and off still) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (I got Moderna as my 1st dose and Pfizer as my 2nd dose) and HEADACHE (having headaches on and off still). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 20-Jun-2021, INTERCHANGE OF VACCINE PRODUCTS (I got Moderna as my 1st dose and Pfizer as my 2nd dose) had resolved. At the time of the report, HEADACHE (having headaches on and off still) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient reported accidentally administered the Pfizer vaccine instead of the Moderna COVID-19 vaccine. Dose 2 Pfizer (non-Moderna) information : Lot #: EW0182 Date administered: 20JUN2021.
7/26/2021 TESTED FOR COVID AT CLINIC RESULTS = DETECTED. 7/28/2021 PATIENT ADMITTED TO HOSPITAL FOR COVID PNA 8/1/2021 PATIENT DIED.
No adverse event or symptoms or side effects. 20 yr pregnat pt (20 wks) was given a Tdap instead of the flu vaccine - med error. Dr notified pt. Next pt returned to clinic for flu vaccine, R deltoid examined - no reaction noted, none reported by pt.
Vaccine was administered outside of 12 hour room temperature expiration period. Vial was removed from refrigerator at 5 PM on Friday evening (8/20/21) and dose was given at approximately 10 AM on Saturday morning, ~5 hours past the 12 hour expiration period for the Moderna vaccine. The manufacturer was contacted and we were instructed that the series in considered complete, no additional doses needed. No adverse event reported from the patient.
Cold sores every since I got the last vaccines; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on an unknown date in 2021 (at the age of 59-year-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the right arm on 27Apr2021 at 14:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any other medications in two weeks. On an unknown date in 2021, the patient experienced cold sores ever since she got the vaccine. The clinical outcome of the event cold sores was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
On December 3, 2022, I experienced nausea and vomiting. I was also tired and achy. I had chills. The next day, I experienced the same symptoms. I tested positive for COVID-19 on December 5, 2022. I had a fever of 100-degrees. I developed a cough. For the rest of the first week, I developed a bit of brain fog along with the cough and tiredness. The following week, the cough continued. I tested negative for COVID-19 on December 14, 2022. My cough got worse. I started cough medicine. I still had a bit of brain fog. I tested negative for COVID-19 again on December 16, 2022. The week of December 19, 2022, I still had a cough, but it seemed more productive. I also had a runny nose. On December 24, 2022, I started to get nauseous again and vomited. I had a fever of 99-degrees. On December 25, 2022, I felt tired, and my stomach didn't feel right. The week of December 26, 2022, I experienced lots of coughing and blew my nose a lot. The week of January 2, 2023, the coughing lessened, but I was still blowing my nose a ton. This week, the coughing lessened more and I'm blowing my nose less, too.
I started getting symptoms of headaches, cough, and chest congestion. I thought it was a cold or sinus infection. Then I got shortness of breath. The cough was getting worse and then I was fatigued. I went to the emergency room and got a COVID-19 test which was positive. I got a breathing treatment while at ER. These symptoms lasted for one week except the chest congestion and cough. I still have chest congestion and cough to this day. I was surprised I caught COVID-19 due to always wearing a mask.
c/o chest pain, shortness of breath, rhinitis, and watery eyes.  Treated with OTC Benadryl.
This spontaneous report was received from a medical assistant and refers to a 8 months old male patient. No information regarding the patient's pertinent medical history, concurrent conditions and drug reactions/allergies was provided. On 02-AUG-2016 at 09:30, the patient was vaccinated with an improperly stored third dose of ROTATEQ lot # L039141 and expiration date 16-AUG-2017, (Strength and dose were not reported), via oral. It was reported that the vaccine was exposed to a temperature excursion described as a minimum (MIN) of 33 Fahrenheit (F) degrees for 10 minutes and a maximum (MAX) of 48 F degrees for 10 minutes. The healthcare worker also stated that the MIN and MAX were not cleared previously. No previous temperature excursion was noted. Patient's concomitant medications was not provided. No adverse effects were reported. A product quality complaint was not involved. This is one of the several reports received from the same source. Additional information is not expected because all follow ups requested to complete the case were received.
Mom did not report the adverse event to our clinic until the next week when she was here for another reason. She reported that the morning of the day after the child had her flu vaccine, she developed hives. Mom did not give any medication but gave her a bath, and the hives disappeared and did not return. There were no other symptoms, no fever and no difficulty breathing.
Fever; chills; sweats; extreme aching in legs; restlessness; pain at point of vaccination; headache; head pounding. Through the night and into the next day 10/30. Alternated between Tylenol and ibuprofen every few hours.
Sore throat, runny nose, "stuffy" head, general malaise, cough-productive white/yellow mucus, hot flashes, chills. Noted 1/2 hour after receiving vaccine and ongoing.
Fever, extremely fussy, cryed constantly of & on & he never did that. Reflux started bad after his vaccines & he now has a dairy allergy he did not have before.
pt complained of flu like symptoms, myalgia, malaise, fever beginning 1 week after immunization
administered on 08/07/2003; administered on 01/30/2003; This spontaneous report has been received from an other health professional, via a medical record from a case in litigation for Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (MARRS # 2303USA000299), concerning 1-day-old female patient.  Concurrent condition and medical history were not reported. Concomitant medications included diphtheria vaccine toxoid (+) pertussis vaccine acellular 3-component (+) tetanus vaccine toxoid (INFANRIX), hib vaccine (HIB), measles (+) mumps (+) and rubella (wistar ra 27-3) virus vaccine (+) live (M-M-R II) and polio vaccine inact (IPV).   On 04-JUN-2002, the patient was vaccinated with the first dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) intramuscular injection, administered for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided). On 30-JAN-2003, the patient was vaccinated with the second dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (Inappropriate schedule of product administration). On 07-AUG-2003, the patient was vaccinated with the third dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (Inappropriate schedule of product administration).  This is one of several reports concerning the same patient.; Sender's Comments:  US-009507513-2303USA000299: US-009507513-2306USA002955:
Several weeks after 2nd dose of Covid19 Pfizer vaccine, pt developed tic like movements that progressively worsened over the next few weeks.
Light-headed, sweaty - dripping on chest area, and passed out on the car ride home ~20-25 minutes after. When I got home, I rested. Ended up with a headache and achy knees - took ibuprofen which helped. Around 8PM, I started getting COVID-toe like symptoms with red toes somewhat inflamed - elevating them helps
Fully vaccinated patient who admitted for increasing shortness of breath and tested "detected" for COVID.  History of COPD and uses supplemental 02 at 2L as norm.  Required BiPAP use for respiratory symptoms, was weaned down to 3L per nasal cannula by discharge.  Required facility placement for further therapy upon discharge due to continued weakness and decrease in ability to care for self independently - goal to go home once stronger.
This case was reported by a consumer via call center representative and described the occurrence of chills in a female patient who received SHINGRIX for prophylaxis. On 25th September 2018, the patient received the 1st dose of SHINGRIX. On 25th September 2018, less than a day after receiving SHINGRIX, the patient experienced chills, fever, headache and nausea. On an unknown date, the outcome of the chills, fever, headache and nausea were unknown. It was unknown if the reporter considered the chills, fever, headache and nausea to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. On the same day of vaccination, at night, the patient experienced chills and fever. The patient also developed a severe headache and nausea that night and the entire next day. The reporter gave consent to follow-up.
had surgery to reconnect retina early Nov2021; he had a mild case of the virus, states got the first two vaccines in Jan and Feb2021; he had a mild case of the virus, states got the first two vaccines in Jan and Feb2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date Feb2021 (Batch/Lot number: unknown) as dose 2, single and administration date Jan2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2021, outcome "unknown" and all described as "he had a mild case of the virus, states got the first two vaccines in Jan and Feb2021"; RETINAL OPERATION (medically significant) with onset Nov2021, outcome "unknown", described as "had surgery to reconnect retina early Nov2021".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
SORE VACCINATION SITE FOR 1 ST DAY, THEN KNOT UNDER SKIN, SWELLING, REDNESS, HEAT, ITCHING, SORENESS FOR  DAYS 2,3,4 AND CONTINUING
mom reported @ f/u pt was fussy & cried for several hrs a day for about 5 days; pt was also reported to have fever to 103;
The first three days after vaccine, I suffered headaches, nausea, fever, tenderness and muscle pain (upper left arm).  The pain in my left arm has continued since 12-04-2019. I am unable to do common things that I did painlessly before the vaccine. Severe, sharp shooting pain occurs when I try to reach back and hook a bra. I am completely unable to do this task the way I used to. Also, reaching back from the car driver's seat to grab the seat belt is very, very painful. I am also unable to reach my left arm up to empty the dishwasher and put the glasses, plates and bowls in the upper cabinets. There are times when I lift a full cup of hot coffee/tea  and have to quickly lower the cup so I don't drop it. My arm aches randomly when I'm not using it. My sleep is disturbed when I roll over in bed onto my left side. The pain is so severe that it wakes me up from a sound sleep. I deeply regret my decision to get a shingles vaccine.
Running high blood sugars high on 2/13/21 at 10:19 pm was 500 gave more  insulin  .   Running average 300  with extra insulin doses.
Afternoon after receiving had fever and chills Went home to bed with 3 blankets. Awoke in middle of night high temp, nausea, vomiting, diarrhea and a terrible headache.  Pretty scary.. almost called 911, could not get up from floor and did not make it to bathroom in time, felt really weak. Next day very weak, headaches, and no taste or smell, loss of appetite. Lay in bed all day weak. finally ate something and diarrhea started back, chills, fever.  Forced fluids and took Excedrin Migraine.  Felt better but later at night diarrhea and headache again. Next morning very weak for work. No taste with metal taste in mouth next two days and very weak with occassional chills and headache;  sweating in bed.  Fifth day developed some productive cough, weak, taste and smell senses returning. Now still slightly weak but getting better. I felt as though a got COVID in a vaccine, was told this is MRNA vaccine, genetically engineered but it seemed live COVID virus.
Information has been received from a grandmother concerning her granddaughter who on approximately 22-AUG-2007 was vaccinated with HPV rL1 6 11 16 18 VLP vaccine (yeast). On approximately 22-AUG-2007 the patient experienced injection site pain. No additional problems were reported. This is one of several reports reported from the same source. Additional information has been requested.
Nausea, vomiting, HA, muscle aching, sore throat, (Lt) arm hurting.
Mild fever of 100.4; Headache; sore arm; fatigue; headache Aches; This is a spontaneous report from a contactable nurse (Patient himself). This 33-year-old male nurse (Patient) received first dose of BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via Intramuscular in left arm on 04Jan2021 at 10:00 and second dose via Intramuscular in left arm on 27Jan2021 at 12:30, both as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. No prior vaccinations within 4 weeks. The patient was diagnosed with COVID-19 prior to vaccination. The patient tested with COVID-19 post vaccination was unknown. On 27Jan2021 at 17:00, the patient experienced mild fever of 100.4, headache aches, sore arm, fatigue. No treatment was received for the adverse events. The outcome of the events was recovering.  Information on the lot/batch number has been requested.  Follow-up (19Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
first 24 hours: nausea, left arm pain and heaviness 1/2/2021 until present: body aches, very strong headache, sore throat, very tired, coughing with pain, flushed, feel as if my eyes are on fire.
body aches; Fever 101 degree celcius; CHILLS; sore arm; This is a spontaneous report from received from a contactable consumer, the patient. This consumer reported different events after each dose of the same product for the same patient; This is the second of two reports. A 47-year-old adult female received the second dose of intramuscular BNT162b2 (solution for injection; Lot EL3249 expiry 31May2021) as a single dose in the right deltoid on 20Jan2021 at 14:00 (at 47-years-old) for COVID-19 immunisation. There was no medical history or concomitant medications reported. The patient previously received her first dose of intramuscular BNT162b2 (Lot EK5730) on 30Dec2020 (at 46-years-old) and donated blood seventeen days later and showed no antibodies. The patient reported that she received the second dose of vaccine on 20Jan2021 at 14:00 and by 21Jan2021 02:00, reported as within twelve hours, she had a sore arm, 101degree Centigrade fever, and body aches and chills. The patient denied any emergency room visit or physician's office visit and was not admitted to the hospital for the events. Post-vaccination antipyretic use on 20Jan202 included oral acetaminophen (TYLENOL) 1000mg, and oral ibuprofen (MOTRIN) 600mg. Treatment was received for the events. The outcome of the events sore arm, 101degree Centigrade fever, and body aches and chills was recovered on unspecified date(s) in 2021.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021056901 PFIZER (Same patient/product; first dose, different event separated in time)